IR-MED Investor Update Letter – Sept-2025
Rosh Pina, Israel--(Newsfile Corp. - September 16, 2025) - IR-MED Inc. (OTCQB: IRME) ("IR-MED" or the "Company"), a developer of non-invasive artificial...
Clinical Trial
Hemostemix to Present Its Clinical Data of the Treatment of Severe Angina
Calgary, Alberta--(Newsfile Corp. - September 16, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's...
Connected Health Market is Projected To Reach US$421.5 Billion By 2031 With CAGR of 6.5% During 2025-2031 | The Insight Partners
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global connected...
Promising New Preclinical Therapy Offers Hope in the Development of Precision Medicine Treatments for Aggressive Cancers
Children's Hospital of Philadelphia Researchers Find New Therapies Show Promise Against ALK-Driven Cancers PHILADELPHIA, Sept. 16, 2025 /PRNewswire/ -- Researchers...
Arterial HealthTech CONNEQT Declares the Future of Heart Health Has Arrived
NAPERVILLE, Ill., Sept. 16, 2025 /PRNewswire/ -- Apple Watch just delivered the alert. The Pulse from CONNEQT Health delivers the answer....
Advarra Launches AI- and Data-Backed Study Design Solution to Improve Operational Efficiency in Clinical Trials
Powered by Braid, Advarra's Recently Introduced Data and AI Engine, the New Solution Unlocks Insightsinto Trial Design Feasibility by Leveraging...
DeepScribe Solidifies Ambient AI Leadership in Oncology with New Study and Accelerated Growth
Study links DeepScribe to improved diagnosis capture and clinician experience, underscoring impact of product innovations and rapid growth in oncology...
PatenSee Receives FDA Breakthrough Device Designation for Non-Contact Vascular Access Management for Patients Undergoing Hemodialysis
Designation supports accelerated development of AI-driven platform to improve outcomes and reduce clinical burden. DETROIT and OR YEHUDA, Israel, Sept....
Expert.ai and Springer Nature Partner to Transform Clinical Trials with AI-Driven Intelligence and Deep Domain Expertise
Strategic collaboration sets a new standard for accelerating drug development through AI-driven insights. PHILADELPHIA, Sept. 16, 2025 /PRNewswire/ -- Expert.ai, a...
Perimeter Medical Imaging AI Partners with Breast Cancer Patient Advocate Jennifer Douglas
Ms. Douglas to support patient engagement initiatives, joins Company's Industry Advisory Board TORONTO and DALLAS, Sept. 16, 2025 /PRNewswire/ -...
Yasir Al-Wakeel Appointed CEO of Vesalius Therapeutics and CEO-Partner of Flagship Pioneering
CAMBRIDGE, Mass., Sept. 16, 2025 /PRNewswire/ -- Flagship Pioneering, a scientific innovation engine for platforms and products, and Vesalius Therapeutics,...
Karmanos Cancer Institute’s BMT, Hematology and Multiple Myeloma Teams Welcome New Physician
Physician specializes in stem cell transplantation for blood cancers DETROIT, Sept. 16, 2025 /PRNewswire/ -- The Barbara Ann Karmanos Cancer...
Aspire Biopharma Announces Initial Production Order of Two Million Servings (100,000 20-packs) of BUZZ BOMB(TM) Pre-Workout Supplement
Part of New Contract Manufacturing Agreement with SupraNaturals to Secure Additional Production CapacitySupraNaturals is a leading private label manufacturer in...
Relmada Regains Compliance with Nasdaq Minimum Bid Price Requirement
CORAL GABLES, Fla., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage...
Mipletamig Delivers 100% Remission Rate in Cohort 3 of RAINIER Trial for AML
No dose-limiting toxicities or cytokine release syndrome observed in RAINIER to date; mipletamig shows consistently favorable safety and tolerabilityTrial progressing...
CytoDyn to Present at the AACR Special Conference: Mechanisms of Cancer Immunity and Cancer-related Autoimmunity
VANCOUVER, Washington, Sept. 16, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a clinical-stage oncology company advancing...
MIRA Pharmaceuticals Reports Positive PTSD Data Demonstrating Ketamir-2 Restores Normalized Behavior in Stressed Animals
MIRA advances Ketamir-2 in the clinic for neuropathic pain while broadening development into neuropsychiatric disorders such as PTSD MIAMI, FLORIDA...
BrainsWay Receives FDA Clearance for Accelerated Deep TMS Protocol for Non-Invasive Treatment of Major Depressive Disorder (MDD)
Clinical data shows that BrainsWay’s new accelerated stimulation protocol is comparable to standard Deep TMS in depression score improvement, response...
BrainsWay Receives FDA Clearance for Accelerated Deep TMS Protocol for Non-Invasive Treatment of Major Depressive Disorder (MDD)
Clinical data shows that BrainsWay’s new accelerated stimulation protocol is comparable to standard Deep TMS in depression score improvement, response...
Jyong Biotech Announces Completion of Patient Enrollment of over 700 subjects in Phase II Clinical Trial of MCS‑8 for Prostate Cancer Prevention
New Taipei City, Taiwan, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company”, “Jyong Biotech”), a...